The 38-year-old actress - who started out as a child on 'The Cosby Show' and then found worldwide fame when she took on the title role of the Disney Channel sitcom 'That's So Raven' - revealed that ...

Patients with ER-positive/HER2-negative metastatic breast cancer who received elacestrant experienced a significant reduction ...

Imlunestrant, an investigational next-generation selective estrogen receptor degrader (SERD), improved progression-free ...

Imlunestrant, an investigational next-generation selective estrogen receptor degrader (SERD), improved progression-free survival in patients with endocrine therapy-pretreated, ER-positive, ...

Patients with germline BRCA mutations who were diagnosed with breast cancer at or before age 40 and who underwent a bilateral risk-reducing mastectomy (RRM) and/or a risk-reducing ...

Patients with high-risk, BRCA-positive breast cancer who received olaparib (Lynparza) after standard treatment continued to ...

The company found that the 1 mg dose of Z-endoxifen reduced MBD by 17.3 percentage points, whereas the 2 mg dose achieved a reduction of 23.5 percentage points. Meanwhile, a minimal change of 0.27 ...

SHIELD study shows reoperation rates dropped from 30% to 10% with use of the Histolog® Scanner, highlighting its potential to improve oncologic surgery and patient outcomes SamanTree Medical, a ...

SamanTree Medical, a leader in oncologic surgical imaging innovation, today announced promising results from the SHIELD study ...

It looks like Eli Lilly’s oral selective estrogen receptor degrader (SERD) imlunestrant may need some extra help to reach a ...

Raven-Symoné recently opened up about undergoing surgery at a very young age. In her comments, the actor stated that she did so after receiving advice that a breast reduction procedure would help her ...

Raven-Symoné recently opened up about undergoing surgery at a very young age. In her comments, the actor stated that she did so after receiving advice that a breast reduction procedure would help her ...